The 10-day RSI Oscillator for QID moved out of overbought territory on November 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In 26 of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QID declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
QID broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on QID as a result. In 82 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for QID just turned positive on October 12, 2026. Looking at past instances where QID's MACD turned positive, the stock continued to rise in 40 of 45 cases over the following month. The odds of a continued upward trend are 89%.
QID moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for QID crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +10.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where QID advanced for three days, in 228 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Aroon Indicator entered an Uptrend today. In 138 of 154 cases where QID Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ROMA advanced for three days, in 119 of 131 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ROMA's RSI Oscillator exited the oversold zone, 10 of 12 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 35 cases where ROMA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ROMA as a result. In 48 of 55 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for ROMA just turned positive on November 03, 2026. Looking at past instances where ROMA's MACD turned positive, the stock continued to rise in 23 of 27 cases over the following month. The odds of a continued upward trend are 85%.
ROMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ROMA entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. ROMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (53.191) is normal, around the industry mean (13.131). P/E Ratio (0.000) is within average values for comparable stocks, (49.500). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.814). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. ROMA's P/S Ratio (400.000) is very high in comparison to the industry average of (26.240).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ROMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
| QID | ROMA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 83% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 89% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 89% | 1 day ago 87% |
| Advances ODDS (%) | 8 days ago 87% | 13 days ago 90% |
| Declines ODDS (%) | 1 day ago 90% | 4 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 87% |
A.I.dvisor tells us that ROMA and AFYA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROMA and AFYA's prices will move in lockstep.
| Ticker / NAME | Correlation To ROMA | 1D Price Change % | ||
|---|---|---|---|---|
| ROMA | 100% | +6.44% | ||
| AFYA - ROMA | 22% Poorly correlated | +1.62% | ||
| EDTK - ROMA | 20% Poorly correlated | +16.30% | ||
| TAL - ROMA | 20% Poorly correlated | +0.30% | ||
| HERE - ROMA | 20% Poorly correlated | +5.92% | ||
| RELX - ROMA | 12% Poorly correlated | -0.37% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPEU | 55.56 | 1.62 | +3.00% |
| State Street SPDR Portfolio Europe ETF (SPEU) | |||
| IGV | 101.46 | 2.58 | +2.61% |
| iShares Expanded Tech-Software Sector ETF (IGV) | |||
| LEXI | 39.77 | 0.85 | +2.17% |
| Alexis Practical Tactical ETF (LEXI) | |||
| LTCC | 10.88 | N/A | N/A |
| Canary Litecoin ETF | |||
| LABD | 6.58 | -0.66 | -9.12% |
| Direxion Daily S&P Biotech Bear 3X ETF (LABD) | |||